Search hospitals > Alabama > Birmingham
Alabama Clinical Therapeutics
Claim this profileBirmingham, Alabama 35235
Global Leader in Human Immunodeficiency Virus Infection
Global Leader in Antiretroviral Therapy
Conducts research for Infections and Infestations
Conducts research for Hypogonadotropic Hypogonadism
Conducts research for Skin and Soft Tissue Infections
162 reported clinical trials
4 medical researchers
Summary
Alabama Clinical Therapeutics is a medical facility located in Birmingham, Alabama. This center is recognized for care of Human Immunodeficiency Virus Infection, Antiretroviral Therapy, Infections and Infestations, Hypogonadotropic Hypogonadism, Skin and Soft Tissue Infections and other specialties. Alabama Clinical Therapeutics is involved with conducting 162 clinical trials across 193 conditions. There are 4 research doctors associated with this hospital, such as Bradley Goodman, MD, Srinivas Mallempati, MD, Robert Foster, MD, and Ronald Orso, MD.Top PIs
Bradley Goodman, MDAlabama Clinical Therapeutics3 years of reported clinical research
Studies Compression Fracture
Studies Hip Fracture
1 reported clinical trial
2 drugs studied
Srinivas Mallempati, MDAlabama Clinical Therapeutics3 years of reported clinical research
Studies Compression Fracture
Studies Hip Fracture
1 reported clinical trial
2 drugs studied
Robert Foster, MDAlabama Clinical Therapeutics5 years of reported clinical research
Studies Venous Reflux Disease
1 reported clinical trial
3 drugs studied
Ronald Orso, MDAlabama Clinical Therapeutics, LLC2 years of reported clinical research
Studies Osteoporosis
Studies Birth Control
1 reported clinical trial
1 drug studied
Clinical Trials running at Alabama Clinical Therapeutics
Disc Degeneration
Osteoarthritis
Birth Control
Compression Fracture
Hip Fracture
Vertebral Compression Fractures
Compression Fractures
Vertebral Compression Fracture
Female
Endometriosis
HYDRAFIL
for Degenerative Disc Disease
A multi-center, prospective, dual arm, randomized, controlled pivotal study to evaluate the safety and effectiveness of the ReGelTec HYDRAFIL™ System.
Recruiting0 awards N/A2 criteria
BRTX-100
for Chronic Lumbar Disc Disease
This is a double-blind, saline-controlled, and randomized study with blinded assessments using a single dose. Subjects that have a current diagnosis of chronic lumbar disc disease and meet eligibility criteria will be enrolled. Chronic lumbar disc disease is defined as back and/or radicular pain with degeneration of the disc confirmed by patient history, physical examination, and radiographic measures such as computed tomography (CT), magnetic resonance imaging (MRI), plain film, myelography, discography, or other acceptable means.
Recruiting0 awards Phase 2
Similar Hospitals nearby
Select from list below to view details
Frequently asked questions
What kind of research happens at Alabama Clinical Therapeutics?
Alabama Clinical Therapeutics is a medical facility located in Birmingham, Alabama. This center is recognized for care of Human Immunodeficiency Virus Infection, Antiretroviral Therapy, Infections and Infestations, Hypogonadotropic Hypogonadism, Skin and Soft Tissue Infections and other specialties. Alabama Clinical Therapeutics is involved with conducting 162 clinical trials across 193 conditions. There are 4 research doctors associated with this hospital, such as Bradley Goodman, MD, Srinivas Mallempati, MD, Robert Foster, MD, and Ronald Orso, MD.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.